Conserved patterns of transcriptional dysregulation, heterogeneity and cell states in clear cell kidney cancer [scRNA-seq]
Single-cell RNA-seq · human · 79 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart.
- Organism
- Homo sapiens (human)
- Topic
- Kidney cancerThis series is part of our curated briefing on it.
- Samples
- 79 samples: 71 distinct titles, 1 of them repeatedGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Conserved patterns of transcriptional dysregulation, heterogeneity, and cell states in clear cell kidney cancerCell reports · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE269826_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA1123757. Searching any of these in the dataset finder brings you back here.
How we read this: Read from 79 sample titles: 71 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8328549 N17 normoxia
- GSM8328550 N17 physoxia
- GSM8328551 N17 hypoxia
- GSM8328552 T17A
- GSM8328553 T17B
- GSM8328554 T17C
- GSM8328555 T17D
- GSM8328556 T17E
- GSM8328557 T17F
- GSM8328558 T17G
- GSM8328559 N18C normoxia
- GSM8328560 N18C physoxia
- GSM8328561 N18C hypoxia
- GSM8328562 N20 normoxia
- GSM8328563 N20 physoxia
- GSM8328564 N20 hypoxia
- GSM8328565 T20AB mix
- GSM8328566 T17A-G mix
- GSM8328567 T17A-G mix DMSO
- GSM8328568 T17A-G mix PT2385
- GSM8328569 N18A
- GSM8328570 N18B
- GSM8328571 N18C
- GSM8328572 N18D
- GSM8328573 T18A
- GSM8328574 T18B
- GSM8328575 N22
- GSM8328576 T22A
- GSM8328577 T22B
- GSM8328578 T22C
- GSM8328579 T22D
- GSM8328580 T22E
- GSM8328581 N23
- GSM8328582 T23A
- GSM8328583 T23B
- GSM8328584 T23C
- GSM8328585 N24
- GSM8328586 T24A
- GSM8328587 T24B
- GSM8328588 N25
+ 39 more — browse all 79 samples with per-sample file links →
- GSE216494 Impact of sunitinib resistance on clear cell renal cell carcinoma therapeutic sensitivity in vitro 12 samples same disease briefing · shares clear
- GSE223688 SETD2 loss sensitizes kidney cancer cells to DNA hypomethylating agents 6 samples same disease briefing · shares kidney
- GSE17895 Somatic Mutation Screen of Clear Cell RCC 160 samples same disease briefing · shares clear
- GSE216495 Nonclinical in-vitro evaluation of the transcriptomic and metabolic effects of immune checkpoint inhibitors on sunitinib-resistant renal cell carcinoma 36 samples same disease briefing
- GSE214635 The E3 ligase RBCK1 reduces the sensitivity of ccRCC to sunitinib through the ANKRD35-MITD1-ANXA1 axis 18 samples same disease briefing
- GSE174740 Drug repurposing identifies a synergistic high-order drug combination to treat sunitinib-resistant renal cell carcinoma 11 samples same disease briefing
- GSE193006 Transcriptome RNA sequencing data of sarcomatoid renal cell carcinoma cell line SRCC and its subclones with different phenotypes. 5 samples same disease briefing
- GSE15641 Gene signatures of progression and metastasis in renal cell cancer 92 samples same disease briefing
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.